Evidence map›Paper›PMID 19261552›Full record

ArticleDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver2009

Determination of Helicobacter pylori virulence by analysis of the cag pathogenicity island isolated from Iranian patients.

K Baghaei, L Shokrzadeh, F Jafari, H Dabiri, Y Yamaoka, M Bolfion, H Zojaji, M M Aslani, M R Zali

Abstract read
In one paragraph

Article in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Transcriptional Profile ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2021
    Article
  4. A new endoscopic submucosal resection -ligation technique for gastric tumors.Gastroenterology and hepatology from bed to bench · 2020
    Article
  5. Review
  6. Article
  7. Predication of hub target genes of differentially expressed microRNAs contributing toGastroenterology and hepatology from bed to bench · 2019
    Article
  8. Article
  9. Prevalence ofGastroenterology and hepatology from bed to bench · 2019
    Article
  10. Article
  11. Eosinophilic gastroenteritis; a report of two cases with different presentations.Gastroenterology and hepatology from bed to bench · 2017
    Article
  12. Occurrence ofGastroenterology and hepatology from bed to bench · 2017
    Article
  13. Pancreatic adenocarcinoma protein-protein interaction network analysis.Gastroenterology and hepatology from bed to bench · 2017
    Article
  14. Study of prevalence, distribution and clinical significance ofGastroenterology and hepatology from bed to bench · 2017
    Article
  15. Article
  16. Protein profiling of infected human gastric epithelial cells with an IranianGastroenterology and hepatology from bed to bench · 2017
    Article
  17. Management of multi-drug resistantGastroenterology and hepatology from bed to bench · 2017
    Review
  18. Article
  19. Helicobacter pylori and gastric cancer: a state of the art review.Gastroenterology and hepatology from bed to bench · 2015
    Review
  20. EPIYA motiefs of cagA and upper gastrointestinal diseases.Gastroenterology and hepatology from bed to bench · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

K BaghaeiResearch Center of Gastroenterology and Liver Diseases in Shahid Beheshti University, Tehran, Iran.
L Shokrzadeh
F Jafari
H Dabiri
Y Yamaoka
M Bolfion
H Zojaji
M M Aslani
M R Zali

Funding

REGULATION OF CXC CHEMOKINE EXPRESSION BY H. PYLORIR01DK062813 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI YAMAOKA, YOSHIO · 2004 to 2013
$3.0M
NIDDK NIH HHS R01 DK062813NIDDK NIH HHS R01 DK62813
6 · The paper itself

Abstract

backgroundThe cag pathogenicity island (PAI), which can be divided into two parts, cagI and cagII, is the most well-known virulence factor of Helicobacter pylori.

aimsWe investigated the association between genetic variations within the cag PAI (cagA and cagE in the cagI and cagT in the cagII) and clinical outcomes in Iranian patients. SUBJECTS: A total of 231 patients including 182 patients with gastritis, 41 with peptic ulcer and 8 with gastric cancer.

methodsThe presence of the cagA, cagE and cagT genes were measured by polymerase chain reaction and the results were compared with clinical outcomes and gastric histology.

resultsThe cagA, cagE and cagT genes were found in 154 (66.7%), 90 (39.0%) and 70 (30.3%) of clinical isolates. At least 144 (62.3%) strains possessed partially deleted cag PAI (e.g., 69 [29.9%] strains were cagA-positive, but cagE and cagT-negative).

conclusionThe single genes as well as the combination of genes in the cag PAI appeared not to be useful markers to predict H. pylori-related diseases in Iranian patients. The genomic sequences of the cag PAI in Iranian strains might be considerably different from those in other geographic locations.

Indexed as

AdolescentAdultAgedAntigens, BacterialBacterial ProteinsFemaleGastritisGenetic VariationGenomic IslandsHelicobacter InfectionsHelicobacter pyloriHumansIranMaleMiddle AgedVirulence FactorsAntigens, BacterialBacterial ProteinscagA protein, Helicobacter pyloriPicB protein, Helicobacter pyloriVirulence Factors

Identifiers

PMID19261552
PMCPMC2784647

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.